Latest News and Press Releases
Want to stay updated on the latest news?
-
Important Synopsys, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 30
-
PHILADELPHIA, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Synopsys, Inc. Stock Dropped 36% on IP Underperformance; Contact BFA Law about the Pending Securities Class Action
-
NEW ORLEANS, Dec. 10, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 30, 2025 to file lead plaintiff applications in...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or...
-
NEW YORK and NEW ORLEANS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with...
-
PHILADELPHIA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
Synopsys, Inc. Hit with Securities Fraud Class Action after IP Underperformance – Contact BFA Law if You Suffered Losses
-
SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of former...